EYPT logo
EyePoint Pharmaceuticals, Inc.(EYPT)
Last print unknown agoAbout this dataData status
$0.44▼-2.55 (-85.28%)Stale · unknown old

EYPT R&D to Revenue

704.60%Fiscal year

Period ending:

EYPT FY R&D/Revenue%
EYPT FY R&D/Revenue1296.86%-100.50%
2001-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

EYPT r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 24 observations from Jun 30, 2001 to Dec 31, 2025.

Eyepoint Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
704.5966%
307.18%
140.5146%
119.8966%
77.1542%
50.5967%
75.4628%
355.6011%
502.5329%
197.3737%
746.1728%
36.0361%
275.6407%
328.4648%
199.6313%
140.8661%
34.733%
118.6154%
576.2371%
655.5796%
607.5149%
780.488%
1,161.6365%
347.6829%

Compare r&d to revenue

All EYPT financial metrics · EYPT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.